MIGUEL
MINGUEZ PEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital de Manises
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Manises (9)
2024
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
2020
-
Clinical assessment of risk factors for infection in inflammatory bowel disease patients
International Journal of Colorectal Disease, Vol. 35, Núm. 3, pp. 491-500
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry
Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616
2018
-
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 535-543
2017
-
Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial
Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1293-1301
-
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry
American Journal of Gastroenterology, Vol. 112, Núm. 7, pp. 1135-1143
2016
-
Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study
Inflammatory Bowel Diseases, Vol. 22, Núm. 4, pp. 894-901
-
Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project
Inflammatory Bowel Diseases, Vol. 22, Núm. 3, pp. 583-589
2015
-
Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps
Gastroenterologia y Hepatologia, Vol. 38, Núm. 6, pp. 355-363